ASMB earnings date and last-quarter result: last quarter beat, P/E -44.90. Updated 2026-07-23.
Assembly Biosciences (ASMB) Research Hub
Assembly Biosciences (ASMB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 19.67 USD (-0.86%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -44.90, market cap 0.41B. This hub links to the full technical, earnings and options research available for ASMB.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 19.67 USD (-0.86%) |
| 52-week range | 19.38 USD – 37 USD |
| Trend regime | Range |
| 14-day RSI | 34.6 (Bearish) |
| Trailing P/E | -44.90 |
| Market cap | 0.41B |
| Dividend yield | 0.00% |
Available research for ASMB
Covered Call on ASMB: how it works, illustrative setup around the real 19.67 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ASMB: how it works, illustrative setup around the real 19.67 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ASMB: how it works, illustrative setup around the real 19.67 USD price, max profit/loss, breakeven and when to use it. Educational.
ASMB technical analysis: range, last 19.67 USD, RSI 34.6, 52w range 19.38 USD–37 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ASMB in?
Assembly Biosciences (ASMB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ASMB in an uptrend or downtrend?
As of 2026-10-26, ASMB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ASMB's trailing P/E ratio?
ASMB's trailing P/E is -44.90, with a market cap of 0.41B. See the earnings research page for full valuation detail.